Actinogen Medical
-
Ticker
ACW
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Sydney, Australia
Actinogen Medical is an ASX-listed biotechnology company developing novel therapies for neurological diseases associated with dysregulated brain cortisol.Actinogen Medical’s lead compound, Xanamem®, has been specifically designed to reduce production of intracellular cortisol - the stress hormone - through the inhibition of the 11β-HSD1 enzyme in the brain.
REPORT RATINGS
4.8 / 5.0 (84)
Actinogen Medical reports have an aggregate usefulness score of 4.8 based on 84 reviews.
Actinogen Medical
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports